NewLeaf Symbiotics

Active#9 worldwide · Biological inputs

Develops biostimulants and biopesticides based on Methylobacterium (PPFM) microbes for corn, soybean and other row crops, applied as seed or in-furrow treatments.

Food & agriculture›Biological inputs newleafsym.com

HQUnited States

Last roundSeries D · Dec 2023

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
Biological inputs · worldwide	Top 32	#9	Edition 0 · Oct 2026	12 Feb 2027

Rank historyOct 2026 · #9 Biological inputsFirst edition: no movements yet.

Estimated valuation

AI · Biological inputs ranking (worldwide)

≈ USD 230MUSD 150–350M · Hundreds of M$

Hundreds of k$

Millions $

Tens of M$

Hundreds of M$

Unicorn

Decacorn

Hectocorn

Anchor: Last known equity round: Series D · USD 45M · Dec 2023

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Funding history

Date	Round	Amount	Type	Investors
Dec 2023	Series D	USD 45M	Equity	Gullspang Re:food, Otter Capital, S2G Ventures, Leaps by Bayer

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of NewLeaf Symbiotics as a PDF. It must answer at least one of these four questions, and stick to them:

AI valuation: $230MUndervalued or overvalued?

Versus competitorsHow does it compare?

Who should acquire itStrategic buyers, and why

Who should it acquireAcquisition targets, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Invest

Back NewLeaf Symbiotics whether or not it has agreed: your intention joins the pool on NewLeaf Symbiotics, passed to the local partner once it reaches critical mass. Declaring an intention does not mean this company is raising funds.

Back NewLeaf Symbiotics Or back biological inputs worldwide

Pool on NewLeaf SymbioticsBelow threshold

BackersBelow threshold

Paid intention · valid for life · movable until a deal process opens. If the company does not follow up, Uback invites its Backers to move their intentions to a competitor or a similar company. Investing in non-listed companies carries a risk of losing all the capital invested.

Do you run NewLeaf Symbiotics?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round.

Claim this profile Report an upcoming round → Report an error →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Read by the AI at the next edition.

Comparable companies in biological inputs

Full biological inputs ranking →

Elicit Plant#8FranceHundreds of M$Micropep#10FranceHundreds of M$Superbac#7BrazilHundreds of M$AgroSpheres#11United StatesHundreds of M$

Investors in NewLeaf Symbiotics: Gullspang Re:food · Otter Capital · S2G Ventures · Leaps by Bayer

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.